An immuno-histochemical study of ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys

Iron is increased in the substantia nigra of patients with Parkinson's disease, but the mechanism of its accumulation is unknown. We report the distribution of ferritin in the basal ganglia of hemiparkinsonian monkeys made by MPTP. We stereotactically injected MPTP unilaterally into the caudate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research 1996-06, Vol.724 (1), p.125-128
Hauptverfasser: Goto, Keigo, Mochizuki, Hideki, Imai, Hisamasa, Akiyama, Haruhiko, Mizuno, Yoshikuni
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 128
container_issue 1
container_start_page 125
container_title Brain research
container_volume 724
creator Goto, Keigo
Mochizuki, Hideki
Imai, Hisamasa
Akiyama, Haruhiko
Mizuno, Yoshikuni
description Iron is increased in the substantia nigra of patients with Parkinson's disease, but the mechanism of its accumulation is unknown. We report the distribution of ferritin in the basal ganglia of hemiparkinsonian monkeys made by MPTP. We stereotactically injected MPTP unilaterally into the caudate nucleus of four monkeys, and the substantia nigra and the basal ganglia regions were stained for l-ferritin by an immunohistochemical method. The ferritin immuno-staining was most intense in the pallidum and the pars reticulata of the substantia nigra on both injected and non-injected sides. No significant difference was noted in the immunostaining for ferritin in the pars compacta of the substantia nigra between the injected and the non-injected side. Iron was increased in the pars compacta of the substantia nigra of this hemiparkinsonian monkeys in our previous study. Normal ferritin immunostaining on the injected side would indicate that iron accumulation is not related to altered metabolism of t,-ferritin in this model.
doi_str_mv 10.1016/0006-8993(96)00284-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_15590290</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0006899396002843</els_id><sourcerecordid>15590290</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-69b38ae836c7e84d0c45ab56526154d9ca7f5d7ae93d572c07b684fb5af9f39c3</originalsourceid><addsrcrecordid>eNp9kM-L1TAQx4Mo63P1P1DoQWQXXjRp0jS5CMviL1hxD-s5pMmUxm2TZ9IKPfqfm_Ie7-hpZpjPfBk-CL2m5D0lVHwghAgslWJXSlwTUkuO2RO0o7Ktsag5eYp2Z-Q5epHzrzIypsgFupCSilqIHfp7Eyo_TUuIePB5jnaAyVszVnle3FrFvuohJT_7goWK4gnmYR0xx4cBQmnovt6zvcAzzMkMq0vxsCbvfIDq6vv9w_019sEtFly1BR9MevQhx-BNqKYYHmHNL9Gz3owZXp3qJfr5-dPD7Vd89-PLt9ubO2y5ZDMWqmPSgGTCtiC5I5Y3pmtEUwvacKesafvGtQYUc01bW9J2QvK-a0yveqYsu0TvjrmHFH8vkGc9-WxhHE2AuGRNm0aRWpEC8iNoU8w5Qa8PyU8mrZoSvZnXm1a9adVqG4p5zcrZm1P-0k3gzkcn1WX_9rQ3uQjukwnW5zPGKBO8bQv28YhBcfHHQ9LZegjFoE9gZ-2i__8f_wDD1qAW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15590290</pqid></control><display><type>article</type><title>An immuno-histochemical study of ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Goto, Keigo ; Mochizuki, Hideki ; Imai, Hisamasa ; Akiyama, Haruhiko ; Mizuno, Yoshikuni</creator><creatorcontrib>Goto, Keigo ; Mochizuki, Hideki ; Imai, Hisamasa ; Akiyama, Haruhiko ; Mizuno, Yoshikuni</creatorcontrib><description>Iron is increased in the substantia nigra of patients with Parkinson's disease, but the mechanism of its accumulation is unknown. We report the distribution of ferritin in the basal ganglia of hemiparkinsonian monkeys made by MPTP. We stereotactically injected MPTP unilaterally into the caudate nucleus of four monkeys, and the substantia nigra and the basal ganglia regions were stained for l-ferritin by an immunohistochemical method. The ferritin immuno-staining was most intense in the pallidum and the pars reticulata of the substantia nigra on both injected and non-injected sides. No significant difference was noted in the immunostaining for ferritin in the pars compacta of the substantia nigra between the injected and the non-injected side. Iron was increased in the pars compacta of the substantia nigra of this hemiparkinsonian monkeys in our previous study. Normal ferritin immunostaining on the injected side would indicate that iron accumulation is not related to altered metabolism of t,-ferritin in this model.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/0006-8993(96)00284-3</identifier><identifier>PMID: 8816266</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine ; Animals ; Biological and medical sciences ; Cell Count ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Ferritin ; Ferritins - analysis ; Immunohistochemistry ; Macaca fascicularis ; Male ; Medical sciences ; Mesencephalon - cytology ; Mesencephalon - physiopathology ; Microglia ; Microglia - metabolism ; MPTP ; Neurology ; Neurons - chemistry ; Neurons - cytology ; Neurons - enzymology ; Oxidative stress ; Oxidative Stress - physiology ; Parkinson Disease, Secondary - chemically induced ; Parkinson Disease, Secondary - metabolism ; Parkinson's disease ; Tyrosine 3-Monooxygenase - analysis</subject><ispartof>Brain research, 1996-06, Vol.724 (1), p.125-128</ispartof><rights>1996</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-69b38ae836c7e84d0c45ab56526154d9ca7f5d7ae93d572c07b684fb5af9f39c3</citedby><cites>FETCH-LOGICAL-c483t-69b38ae836c7e84d0c45ab56526154d9ca7f5d7ae93d572c07b684fb5af9f39c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0006-8993(96)00284-3$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3136477$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8816266$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goto, Keigo</creatorcontrib><creatorcontrib>Mochizuki, Hideki</creatorcontrib><creatorcontrib>Imai, Hisamasa</creatorcontrib><creatorcontrib>Akiyama, Haruhiko</creatorcontrib><creatorcontrib>Mizuno, Yoshikuni</creatorcontrib><title>An immuno-histochemical study of ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Iron is increased in the substantia nigra of patients with Parkinson's disease, but the mechanism of its accumulation is unknown. We report the distribution of ferritin in the basal ganglia of hemiparkinsonian monkeys made by MPTP. We stereotactically injected MPTP unilaterally into the caudate nucleus of four monkeys, and the substantia nigra and the basal ganglia regions were stained for l-ferritin by an immunohistochemical method. The ferritin immuno-staining was most intense in the pallidum and the pars reticulata of the substantia nigra on both injected and non-injected sides. No significant difference was noted in the immunostaining for ferritin in the pars compacta of the substantia nigra between the injected and the non-injected side. Iron was increased in the pars compacta of the substantia nigra of this hemiparkinsonian monkeys in our previous study. Normal ferritin immunostaining on the injected side would indicate that iron accumulation is not related to altered metabolism of t,-ferritin in this model.</description><subject>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cell Count</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Ferritin</subject><subject>Ferritins - analysis</subject><subject>Immunohistochemistry</subject><subject>Macaca fascicularis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mesencephalon - cytology</subject><subject>Mesencephalon - physiopathology</subject><subject>Microglia</subject><subject>Microglia - metabolism</subject><subject>MPTP</subject><subject>Neurology</subject><subject>Neurons - chemistry</subject><subject>Neurons - cytology</subject><subject>Neurons - enzymology</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - physiology</subject><subject>Parkinson Disease, Secondary - chemically induced</subject><subject>Parkinson Disease, Secondary - metabolism</subject><subject>Parkinson's disease</subject><subject>Tyrosine 3-Monooxygenase - analysis</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM-L1TAQx4Mo63P1P1DoQWQXXjRp0jS5CMviL1hxD-s5pMmUxm2TZ9IKPfqfm_Ie7-hpZpjPfBk-CL2m5D0lVHwghAgslWJXSlwTUkuO2RO0o7Ktsag5eYp2Z-Q5epHzrzIypsgFupCSilqIHfp7Eyo_TUuIePB5jnaAyVszVnle3FrFvuohJT_7goWK4gnmYR0xx4cBQmnovt6zvcAzzMkMq0vxsCbvfIDq6vv9w_019sEtFly1BR9MevQhx-BNqKYYHmHNL9Gz3owZXp3qJfr5-dPD7Vd89-PLt9ubO2y5ZDMWqmPSgGTCtiC5I5Y3pmtEUwvacKesafvGtQYUc01bW9J2QvK-a0yveqYsu0TvjrmHFH8vkGc9-WxhHE2AuGRNm0aRWpEC8iNoU8w5Qa8PyU8mrZoSvZnXm1a9adVqG4p5zcrZm1P-0k3gzkcn1WX_9rQ3uQjukwnW5zPGKBO8bQv28YhBcfHHQ9LZegjFoE9gZ-2i__8f_wDD1qAW</recordid><startdate>19960610</startdate><enddate>19960610</enddate><creator>Goto, Keigo</creator><creator>Mochizuki, Hideki</creator><creator>Imai, Hisamasa</creator><creator>Akiyama, Haruhiko</creator><creator>Mizuno, Yoshikuni</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>19960610</creationdate><title>An immuno-histochemical study of ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys</title><author>Goto, Keigo ; Mochizuki, Hideki ; Imai, Hisamasa ; Akiyama, Haruhiko ; Mizuno, Yoshikuni</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-69b38ae836c7e84d0c45ab56526154d9ca7f5d7ae93d572c07b684fb5af9f39c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cell Count</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Ferritin</topic><topic>Ferritins - analysis</topic><topic>Immunohistochemistry</topic><topic>Macaca fascicularis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mesencephalon - cytology</topic><topic>Mesencephalon - physiopathology</topic><topic>Microglia</topic><topic>Microglia - metabolism</topic><topic>MPTP</topic><topic>Neurology</topic><topic>Neurons - chemistry</topic><topic>Neurons - cytology</topic><topic>Neurons - enzymology</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - physiology</topic><topic>Parkinson Disease, Secondary - chemically induced</topic><topic>Parkinson Disease, Secondary - metabolism</topic><topic>Parkinson's disease</topic><topic>Tyrosine 3-Monooxygenase - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goto, Keigo</creatorcontrib><creatorcontrib>Mochizuki, Hideki</creatorcontrib><creatorcontrib>Imai, Hisamasa</creatorcontrib><creatorcontrib>Akiyama, Haruhiko</creatorcontrib><creatorcontrib>Mizuno, Yoshikuni</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goto, Keigo</au><au>Mochizuki, Hideki</au><au>Imai, Hisamasa</au><au>Akiyama, Haruhiko</au><au>Mizuno, Yoshikuni</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An immuno-histochemical study of ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>1996-06-10</date><risdate>1996</risdate><volume>724</volume><issue>1</issue><spage>125</spage><epage>128</epage><pages>125-128</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Iron is increased in the substantia nigra of patients with Parkinson's disease, but the mechanism of its accumulation is unknown. We report the distribution of ferritin in the basal ganglia of hemiparkinsonian monkeys made by MPTP. We stereotactically injected MPTP unilaterally into the caudate nucleus of four monkeys, and the substantia nigra and the basal ganglia regions were stained for l-ferritin by an immunohistochemical method. The ferritin immuno-staining was most intense in the pallidum and the pars reticulata of the substantia nigra on both injected and non-injected sides. No significant difference was noted in the immunostaining for ferritin in the pars compacta of the substantia nigra between the injected and the non-injected side. Iron was increased in the pars compacta of the substantia nigra of this hemiparkinsonian monkeys in our previous study. Normal ferritin immunostaining on the injected side would indicate that iron accumulation is not related to altered metabolism of t,-ferritin in this model.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>8816266</pmid><doi>10.1016/0006-8993(96)00284-3</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-8993
ispartof Brain research, 1996-06, Vol.724 (1), p.125-128
issn 0006-8993
1872-6240
language eng
recordid cdi_proquest_miscellaneous_15590290
source MEDLINE; Elsevier ScienceDirect Journals
subjects 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Animals
Biological and medical sciences
Cell Count
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Ferritin
Ferritins - analysis
Immunohistochemistry
Macaca fascicularis
Male
Medical sciences
Mesencephalon - cytology
Mesencephalon - physiopathology
Microglia
Microglia - metabolism
MPTP
Neurology
Neurons - chemistry
Neurons - cytology
Neurons - enzymology
Oxidative stress
Oxidative Stress - physiology
Parkinson Disease, Secondary - chemically induced
Parkinson Disease, Secondary - metabolism
Parkinson's disease
Tyrosine 3-Monooxygenase - analysis
title An immuno-histochemical study of ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T13%3A36%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20immuno-histochemical%20study%20of%20ferritin%20in%201-methyl-4-phenyl-1,2,3,6-tetrahydropyridine%20(MPTP)-induced%20hemiparkinsonian%20monkeys&rft.jtitle=Brain%20research&rft.au=Goto,%20Keigo&rft.date=1996-06-10&rft.volume=724&rft.issue=1&rft.spage=125&rft.epage=128&rft.pages=125-128&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/0006-8993(96)00284-3&rft_dat=%3Cproquest_cross%3E15590290%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15590290&rft_id=info:pmid/8816266&rft_els_id=0006899396002843&rfr_iscdi=true